Impact Ethics

NTE Events Archive

Events, By Category and Date:

Subscribe

Upcoming and most recent events are listed below in reverse order. For other archived events, please see the categories on the menu to the right, or 'View past items' to access archives by date.


nte  –  In Action
Wednesday, October 28, 2020
Françoise Baylis is interviewed regarding ethical failures and the failure to negotiate between Dalhousie Board of Governors and Dalhousie Faculty Association.
nte  –  In Print
Wednesday, October 7, 2020
Françoise Baylis and Landon J. Getz explain the ethical challenges of human challenge trials to test candidate COVID-19 vaccines.
nte  –  In Print
Friday, September 25, 2020
Andrew Fenton and L. Syd M Johnson outline several ethical issues with nonhuman animal research revealed by COVID-19 research.
nte  –  In Action
Monday, September 14, 2020
Françoise Baylis is interviewed by Portia Clark on Nova Scotia's proposed legislation (January 2021) which will make organ "donation" an opt-out—rather than opt-in, voluntary—policy.
nte  –  In Action
Wednesday, September 9, 2020
CRISPR gene-editing technology is advancing quickly. Françoise Baylis is interviewed in this podcast on the ethical dimensions about what this technology can do now and what it might change for us now and into the future.
nte  –  In Action
Monday, June 8, 2020
Françoise Baylis helps lead a panel discussion with Parmy Olson, Rachel Neaman and Charolotte Augst as part of the CogX 2020 conference (London UK, 8 June 2020, 5:00PM-5:45PM BST)
nte  –  In Action
Wednesday, May 20, 2020
Kat Eschner interviews Françoise Baylis and reviews her book, ALTERED INHERITANCE.
nte  –  In Print
Thursday, May 7, 2020
Françoise Baylis and Natalie Kofler argue against using immunity passports for COVID-19.
nte  –  In Print
Friday, May 1, 2020
Françoise Baylis argues that Canada needs one (not many local) triage protocol for the COVID-19 pandemic.
nte  –  In Print
Monday, April 27, 2020
Andrew Fenton reflects on a recent Science magazine article outlining the management of some laboratory rodent populations as a result of COVID-19.
View past items